Chemotherapy-induced peripheral neuropathy (CIPN) and vitamin B12 deficiency
摘要:
Introduction Chemotherapy-induced peripheral neuropathy (CIPN) continues to be a major concern for oncological practise considering the increasing number of cancer survivors and the lack of standardised prevention or treatment [ 1 ]. The incidence of CIPN depends on the chemotherapy agent administered but is estimated to occur in one third of all patients undergoing chemotherapy [ 2 , 3 ]. The prevalence of CIPN has been estimated to be 68.1% the first month after the administration of neurotoxic chemotherapy agents and 60% 3months post chemotherapy treatment. Patients were found to still have 30% prevalence 6months or more after chemotherapy according to the results published in a systematic review conducted in 2014 [ 4 ]. Patients experiencing moderate to severe CIPN report a reduced quality of life [ 5 ], chronic discomfort [ 6 ] and disruption of physical abilities for general life activities which can be temporary or permanent [ 5 ]. Currently in clinical practise, CIPN is assessed using th ...
展开
关键词:
Chemotherapy Administration Princess Alexandra Hospital Raise Liver Enzyme Patient Neurotoxicity Questionnaire Intrinsic Factor Antibody
DOI:
10.1007/s00520-015-2725-6
被引量:
年份:
2015



































通过文献互助平台发起求助,成功后即可免费获取论文全文。
相似文献
参考文献
引证文献
引用走势
辅助模式
引用
文献可以批量引用啦~
欢迎点我试用!